Tweet

Re-Check

19 Feb, 4 tweets, 5 min read

@RecheckHealth

1/3 Just out: @RecheckHealth analysis and commentary Der seltsame Fall / le cas étrange / the Strange Case of the Swiss National COVID-19 Science Task Force @SwissScience_TF. Open access in Deutsch / Français / English. re-check.ch/wordpress/fr/s…

@SwissScience_TF

2/3 @SwissScience_TF is a group of scientists acting as a consultant to the Swiss authorities on #COVID19. Only his president should be talking to the media; is it really the case? And what are the rules of engagement of this very special board? @RecheckHealth

@RecheckHealth

3/3 @RecheckHealth filed several #FOIA, and analysed ten months of communication and scientific work of the Swiss National COVID-19 Science Task Force. Spoiler alert: Houston, we have a problem. #transparenzstory #Öffentlichkeitsgesetz #PandemicScience #EBM

@RecheckHealth

#openaccess Analysis pieces published on @RecheckHealth website can be republished after checking in with us: they are licensed under creativecommons.org/licenses/by-nc… Documents obtained with #FOI #BGÖ #LTrasp are linked in the article. We anonymise telephone numbers and email addresses.

• • •

Missing some Tweet in this thread? You can try to force a refresh

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @RecheckHealth

Re-Check

@RecheckHealth

11 Feb

@RecheckHealth

1/9 Has #Gardasil approval ushered in an era of #overprevention? @RecheckHealth’s @CatherineRiva published on @thejospi an intriguing, original research piece co-signed by MD Jean-Pierre Spinosa: jospi.org/article/18180-… #HPV

@CatherineRiva

2/9 The article tracks back the approval history of the first vaccine to have been granted the FDA’s accelerated approval and fast track. @CatherineRiva and MD @gipispinosa combined published documents with DAPs and correspondence obtained with a #FOIA #Gardasil #HPV

@thejospi

3/9 The authors of @thejospi piece sought to understand how the evaluation criteria were selected during #Gardasil approval and the impact of the FDA experts’ choices on the quality of the available evidence about the vaccine’s efficacy. #Gardasil #HPV

Read 9 tweets

Re-Check

@RecheckHealth

19 Feb 20

@Doctors4Assange

1/
.@Doctors4Assange published in @TheLancet on behalf of 117 signatories hbs.ly/H02z580 “We are calling upon governments to end the torture of #Assange and ensure his access to the best available health care before it’s too late”

@RecheckHealth

2/
.@RecheckHealth co-founders @serenatinari and @CatherineRiva who co-launched #JournalistSpeakUpForAssange fully endorse this appeal

@NilsMelzer

3/
#SRFrundschau will interview tonight @NilsMelzer on #Assange case and the issue of a #humanitarian #visa for him in Canton of #Geneva srf.ch/news/internati…

Read 4 tweets

Re-Check

@RecheckHealth

19 Jan 19

@VPrasadMDMPH

Care to kick off the New Year with a TWEETORIAL? Our humble homage to @VPrasadMDMPH will walk you through the evidence on #HPV vaccines and what @Cochranecollab made of it. Let’s first agree on one thing: RCTs are superior to observational studies

@garyschwitzer

On HPV vaccines many observational studies published and hyped Randomized Controlled Trials on #Gardasil #Cervarix failed to demonstrate the expected efficacy though. It is sad, true and rarely discussed. Let’s have a closer look. @garyschwitzer @HealthNewsRevu @senseaboutsci

@US_FDA

In 2006 @US_FDA VRBPAC Committee required @Merck to provide data and analyses on Gardasil RCTs FUTURE I and II.
Which outcome would you consider as the most relevant to assess Gardasil efficacy?

Read 22 tweets

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!